Study to Assess Accuracy of Rapid Mood Screener in Adult Participants With Unipolar Major Depressive Disorder or Bipolar 1 Disorder in Real World Setting

CompletedOBSERVATIONAL
Enrollment

423

Participants

Timeline

Start Date

December 4, 2023

Primary Completion Date

August 16, 2024

Study Completion Date

August 16, 2024

Conditions
Bipolar I Disorder
Trial Locations (9)

33145

MedOne Clinical Research /ID# 263031, Miami

92626-4607

ATP Clinical Research, Inc /ID# 255223, Costa Mesa

06416

CT Clinical Research /ID# 253488, Cromwell

33126-1829

UHC Research /ID# 263151, Doral

33126-1834

J&A Clinical Research /ID# 263034, Doral

33169-5510

Oceanic Research Group /ID# 263032, North Miami Beach

34972-2568

Health Synergy Clinical Research LLC /ID# 262998, Okeechobee

33629-5837

Interventional Psychiatry of Tampa Bay /ID# 253526, Tampa

10952-1233

Richard Louis Price, M.D., LLC /ID# 253527, Monsey

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY